新芝生物
(920685)
| 流通市值：8.63亿 | | | 总市值：14.41亿 |
| 流通股本：5477.86万 | | | 总股本：9151.60万 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 114,171,509.27 | 71,149,555.52 | 32,661,264.97 | 168,092,009.31 |
| 营业收入 | 114,171,509.27 | 71,149,555.52 | 32,661,264.97 | 168,092,009.31 |
| 二、营业总成本 | 92,159,963.11 | 58,867,387.47 | 26,613,381.96 | 132,795,178.43 |
| 营业成本 | 42,583,622.74 | 26,694,563.99 | 12,009,120.34 | 64,652,854.66 |
| 税金及附加 | 1,661,784.89 | 1,061,638.04 | 502,673.84 | 2,345,238.14 |
| 销售费用 | 18,863,955.5 | 11,713,804.14 | 5,284,626.37 | 26,000,545.47 |
| 管理费用 | 16,470,640.77 | 11,428,371.85 | 5,523,560.17 | 23,863,703.1 |
| 研发费用 | 13,102,305.8 | 8,481,346.28 | 3,658,992.32 | 17,738,026.42 |
| 财务费用 | -522,346.59 | -512,336.83 | -365,591.08 | -1,805,189.36 |
| 其中:利息费用 | 128,067.12 | 83,611.51 | 35,331.88 | 186,244.42 |
| 其中:利息收入 | 694,504.68 | 553,886.56 | 336,645.82 | 1,973,190.46 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 2,425,059.92 | 1,598,663.34 | 762,343.28 | 3,163,765.13 |
| 加:投资收益 | 1,696,820.57 | 1,125,535.31 | 651,636.68 | 2,752,930.97 |
| 资产处置收益 | - | - | -9,174.31 | 13,680,415.14 |
| 资产减值损失(新) | -1,122,985.11 | -1,298,986.72 | -375,171.49 | -1,804,158.47 |
| 信用减值损失(新) | -238,534.63 | -77,260.5 | 18,925.9 | -187,502.97 |
| 其他收益 | 4,577,109.14 | 2,847,509.8 | 1,789,123.48 | 6,464,302.4 |
| 四、营业利润 | 29,349,016.05 | 16,477,629.28 | 8,885,566.55 | 59,366,583.08 |
| 加:营业外收入 | 35,654.02 | 45,254.81 | 45,253.19 | 1,009,708.79 |
| 减:营业外支出 | 55,662.02 | 13,543.67 | 723.39 | 569,560.8 |
| 五、利润总额 | 29,329,008.05 | 16,509,340.42 | 8,930,096.35 | 59,806,731.07 |
| 减:所得税费用 | 2,495,868.07 | 1,364,738.36 | 1,047,870.65 | 8,159,700.9 |
| 六、净利润 | 26,833,139.98 | 15,144,602.06 | 7,882,225.7 | 51,647,030.17 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 26,833,139.98 | 15,144,602.06 | 7,882,225.7 | 51,647,030.17 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 20,709,090.01 | 11,865,551.27 | 6,501,584.76 | 41,627,687.27 |
| 少数股东损益 | 6,124,049.97 | 3,279,050.79 | 1,380,640.94 | 10,019,342.9 |
| 扣除非经常损益后的净利润 | 15,530,837.13 | 8,928,793.43 | 4,994,111.52 | 28,264,779.43 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.23 | 0.13 | 0.07 | 0.47 |
| (二)稀释每股收益 | 0.23 | 0.13 | 0.07 | 0.47 |
| 九、综合收益总额 | 26,833,139.98 | 15,144,602.06 | 7,882,225.7 | 51,647,030.17 |
| 归属于母公司股东的综合收益总额 | 20,709,090.01 | 11,865,551.27 | 6,501,584.76 | 41,627,687.27 |
| 归属于少数股东的综合收益总额 | 6,124,049.97 | 3,279,050.79 | 1,380,640.94 | 10,019,342.9 |
| 公告日期 | 2025-10-29 | 2025-08-26 | 2025-04-28 | 2025-04-21 |
| 审计意见(境内) | | | | 标准无保留意见 |